Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market Set For Robust Growth Driven By Promising Pipeline Therapies And Advancements In Gene Editing Technologies Delveinsight
12 Nov 2025 | Category: Science
(MENAFN - GetNews) "Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market"Key Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Companies, including Pfizer, Alnylam Pharmaceuticals, Ionis ...
🔗 Read More at Original Source
Source:
Menafn
| 12 Nov 2025
Related Articles
A Giant Hole Is Tearing Through Earth’s Magnetic Field - And It’s Getting Worse
An expanding weak spot in Earth’s magnetic field has been growing steadily for more than a decade over the South Atlantic Ocean, …
Source:
Indian Defence Review
| 12 Nov 2025
Efficient PVP Replacement for Silver Nanowires Developed
Researchers at UNIST have introduced a straightforward yet efficient technique to substitute the insulating layer, polyvinylpyrrolidone (PVP), that envelops silver nanowires (AgNWs), …
Source:
AZoNano
| 12 Nov 2025
Researchers Identify First True Ferrielectric Material in Single
Researchers have identified the first true ferrielectri […]
Source:
geneonline.com
| 12 Nov 2025